TP53 and neoplasm: The data also illustrate how MDM2, depending on cellular conditions and via different RNA binding domains, binds the p53 or E2F1 mRNAs and thereby acts as an oncogene or tumour suppressor and how p14Arf manages MDM2’s activity towards p53 and E2F1.